NCT05641961 Mobile App to Help Survivors of Childhood Cancer Navigate Long-Term Follow-Up Care
| NCT ID | NCT05641961 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, San Francisco |
| Condition | Childhood Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2022-11-29 |
| Primary Completion | 2026-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2022-11-29 with a primary completion date of 2026-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This clinical trial studies the effectiveness of a newly developed survivorship mobile application (app) designed for survivors, or their caregivers, of childhood cancer to help them better navigate long-term follow-up care. The survivorship app provides survivors access to their treatment history and follow-up recommendations, improves knowledge of their diagnosis, treatment, risks, and recommended follow-up care by using a message notification. The ability to quickly connect and establish care planning may enhance adherence to recommended follow-up.
Eligibility Criteria
Inclusion Criteria: * Survivors of childhood cancer attending Survivorship Clinic at University of California, San Francisco (UCSF) OR caregivers of a childhood cancer survivor attending Survivorship Clinic at UCSF. * Must have a mobile device (smartphone or smart-tablet) with service plan. * Must have ability to read, write, and understand English language. Exclusion Criteria: * An individual who does not meet any of the criteria mentioned above will be excluded from participation in this study.
Contact & Investigator
Robert Goldsby, MD
PRINCIPAL INVESTIGATOR
University of California, San Francisco
Frequently Asked Questions
Who can join the NCT05641961 clinical trial?
This trial is open to participants of all sexes, studying Childhood Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05641961 currently recruiting?
Yes, NCT05641961 is actively recruiting participants. Contact the research team at Patricia.Murphy@ucsf.edu for enrollment information.
Where is the NCT05641961 trial being conducted?
This trial is being conducted at San Francisco, United States.
Who is sponsoring the NCT05641961 clinical trial?
NCT05641961 is sponsored by University of California, San Francisco. The principal investigator is Robert Goldsby, MD at University of California, San Francisco. The trial plans to enroll 30 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.